XML 58 R48.htm IDEA: XBRL DOCUMENT v3.25.0.1
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2024
Income Tax Disclosure [Abstract]  
Components of Federal and State Income Tax Expense

The components of federal and state income tax expense for the years ended December 31, 2024, 2023, and 2022 were as follows (in thousands):

 

 

 

2024

 

 

2023

 

 

2022

 

Current

 

 

 

 

 

 

 

 

 

Federal

 

$

18,504

 

 

$

2,189

 

 

$

14,401

 

State

 

 

6,404

 

 

 

542

 

 

 

6,171

 

Total current

 

 

24,908

 

 

 

2,731

 

 

 

20,572

 

Deferred

 

 

 

 

 

 

 

 

 

Federal

 

 

(2,497

)

 

 

12,585

 

 

 

(2,005

)

State

 

 

3,087

 

 

 

4,154

 

 

 

(227

)

Total deferred

 

 

590

 

 

 

16,739

 

 

 

(2,232

)

Total

 

$

25,498

 

 

$

19,470

 

 

$

18,340

 

Effective Income Tax Reconciliation The principal reasons for the difference are as follows (in thousands):

 

 

 

 

2024

 

 

2023

 

 

2022

 

Expected income taxes

 

$

21,923

 

 

$

18,565

 

 

$

19,172

 

Effects of:

 

 

 

 

 

 

 

 

 

Tax-exempt income from bank owned life insurance

 

 

(994

)

 

 

(1,035

)

 

 

(659

)

Other tax exempt income

 

 

(2,397

)

 

 

(2,416

)

 

 

(2,497

)

Nondeductible interest expense

 

 

307

 

 

 

799

 

 

 

255

 

State taxes, net of federal taxes

 

 

4,917

 

 

 

3,710

 

 

 

4,695

 

Other items

 

 

(839

)

 

 

(153

)

 

 

(2,525

)

Effect of marginal tax rate

 

 

2,581

 

 

 

 

 

 

(101

)

Total

 

$

25,498

 

 

$

19,470

 

 

$

18,340

 

Tax Effects of Temporary Differences on Deferred Tax Assets and Deferred Tax Liabilities

The tax effects of the temporary differences that gave rise to significant portions of the deferred tax assets and deferred tax liabilities at December 31, 2024 and 2023 are presented below (in thousands):

 

 

 

2024

 

 

2023

 

Deferred tax assets:

 

 

 

 

 

 

Allowance for credit losses

 

$

18,588

 

 

$

18,955

 

Available-for-sale investment securities

 

 

49,082

 

 

 

55,722

 

Deferred compensation

 

 

4,377

 

 

 

4,128

 

Supplemental retirement

 

 

512

 

 

 

519

 

Deferred loan costs

 

 

462

 

 

 

222

 

Stock compensation expense

 

 

80

 

 

 

82

 

Deferred revenue

 

 

211

 

 

 

283

 

Purchase accounting

 

 

 

 

 

5,326

 

Acquisition costs

 

 

112

 

 

 

152

 

Lease liability

 

 

3,743

 

 

 

3,975

 

Other

 

 

3,623

 

 

 

1,305

 

Total gross deferred tax assets

 

 

80,790

 

 

 

90,669

 

Less valuation allowance

 

 

(682

)

 

 

(988

)

Net deferred tax asset

 

 

80,108

 

 

 

89,681

 

Deferred tax liabilities:

 

 

 

 

 

 

Intangibles amortization

 

 

5,378

 

 

 

6,432

 

Prepaid expenses

 

 

2,023

 

 

 

1,576

 

FHLB stock dividend

 

 

21

 

 

 

22

 

Deferred expenses

 

 

100

 

 

 

104

 

Purchase accounting

 

 

1,854

 

 

 

 

Depreciation

 

 

4,517

 

 

 

5,367

 

Accumulated accretion

 

 

222

 

 

 

244

 

Mortgage servicing rights

 

 

1,485

 

 

 

1,874

 

Right of use asset

 

 

3,657

 

 

 

3,891

 

Other

 

 

1,265

 

 

 

104

 

Total gross deferred tax liabilities

 

 

20,522

 

 

 

19,614

 

Deferred tax assets, net

 

$

59,586

 

 

$

70,067

 

In assessing the ability of the Company to realize the benefit of the deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. Based upon the level of historical taxable income and projections for future taxable income over the periods which deferred tax assets are deductible, management believes it is more likely than not the Company will generate sufficient taxable income to realize the benefits of these deductible differences at December 31, 2024 and 2023, except for a valuation allowance of $682,000 and $988,000, respectively, on the net deferred tax asset related to capital losses generated. In assessing the need for a valuation allowance for the deferred tax assets for the capital loss carryforward, the Company considered all positive and negative evidence in assessing whether the weight of available evidence supports the recognition of some or all of the deferred tax assets related to these carryforwards. The Company may not be able to generate capital gains in the future to be able to utilize the capital losses. Therefore, the Company’s assessment of the deferred tax asset warrants the need for a valuation allowance.